Louria Hayon Igal
Transaction: 11/20/2025
SELL
Change
-350,000
Price
$0.01
Filing
04/06/2026
Type
SELL
Raphael Pharmaceutical Inc.
RAPH • Drug Manufacturers - Specialty & Generic
$1.40
— 0.00 (0.00%)
Current price
EarningsLatest report: Mar 31, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$28.25M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Weak liquidity · 0.03Weak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 14, 2026, 12:00 AM UTCLast profile update: Aug 16, 2026, 12:14 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$1.40
Change0.00%
Shares Out20.18M
Market Cap$28.25M
Enterprise Value$28.25M
52W Range0.22 - 1.40
Beta1.90
P/E-26.18
P/B-14.99
P/FCF-1,883.13
EV/EBITDA-27.08
EV/FCF-1,883.07
Price$1.40
Change0.00%
Shares Out20.18M
Market Cap$28.25M
Enterprise Value$28.25M
52W Range0.22 - 1.40
Beta1.90
P/E-26.18
P/B-14.99
P/FCF-1,883.13
EV/EBITDA-27.08
EV/FCF-1,883.07
Earnings Yield-3.82%
FCF Yield-0.05%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio0.03
Quick Ratio0.03
Volume140.00
Avg Volume177.00
Investment DNA
How strong this company looks for long-term investors
33
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
20/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
50/100
Why this score▼
Manageable debt level · 0Weak liquidity · 0.03Weak profitability
Analyst view
No analyst data available now.
Financial Health
Score4 / 20
Debt / Equity: 0.00
Current Ratio: 0.03
Quick Ratio: 0.03
Status: HighRisk
Warnings
- Weak Liquidity
- Weak quick ratio
Insider Transactions
Recent executive and insider activity
⚠ 3 high-volume insider sells detected
Louria Hayon Igal
Transaction: 11/20/2025
BUY
Change
+350,000
Price
$0.01
Filing
04/06/2026
Type
BUY
Laor Zvi Laufer
Transaction: 08/01/2025
OTHER
Change
0
Price
Not reported
Filing
09/08/2025
Type
OTHER
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Louria Hayon Igal | SELL | -350,000 | $0.01 | 11/20/2025 | 04/06/2026 |
| Louria Hayon Igal | BUY | +350,000 | $0.01 | 11/20/2025 | 04/06/2026 |
| Laor Zvi Laufer | OTHER | 0 | Not reported | 08/01/2025 | 09/08/2025 |
| Eliya Yehuda | BUY | +200,000 | $1.00 | 03/10/2025 | 03/12/2025 |
| Eliya Yehuda | SELL | -202,000 | $1.12 | 05/12/2022 | 03/12/2025 |
| Pilo Shlomo | BUY | +100,000 | $1.00 | 03/02/2025 | 03/11/2025 |
| Pilo Shlomo | BUY | +200,000 | $0.50 | 03/02/2025 | 03/11/2025 |
| Dhadha Ajay Kumar | BUY | +250,000 | $1.00 | 03/05/2025 | 03/06/2025 |
| Dhadha Ajay Kumar | BUY | +350,000 | Not reported | 03/05/2025 | 03/06/2025 |
| Dhadha Ajay Kumar | OTHER | 0 | Not reported | 01/08/2025 | 02/13/2025 |
| Eliya Yehuda | BUY | +150,000 | $0.40 | 11/25/2023 | 03/25/2024 |
| Louria Hayon Igal | SELL | -999,000 | $0.01 | 08/29/2023 | 03/25/2024 |
| Louria Hayon Igal | BUY | +999,000 | $0.01 | 08/29/2023 | 03/25/2024 |
| Ofir Guy | BUY | +1,000,000 | $1.00 | 12/05/2022 | 03/13/2023 |
| Louria Hayon Igal | BUY | +999,000 | $0.01 | 12/05/2022 | 03/13/2023 |
| Press Joseph | BUY | +105,000 | $1.12 | 12/05/2022 | 03/13/2023 |
| Pilo Shlomo | BUY | +1,000,000 | $1.12 | 12/05/2022 | 03/13/2023 |
| Eliya Yehuda | BUY | +202,000 | $1.12 | 12/05/2022 | 03/13/2023 |
| Ofir Guy | BUY | +1,000,000 | Not reported | 07/26/2022 | 03/13/2023 |
| Press Joseph | BUY | +280,000 | Not reported | 07/26/2022 | 03/13/2023 |